Hikes FY guidance (Il Sole 24 Ore Radiocor) - Paris, 05 Sep - BioMerieux, a French provider of in vitro diagnostics, said that in the first half organic sales rose 9.9% to 1.902 billion euros.

Sales of Biofire non-respiratory panels rose 19%, while revenue of the microbiology business grew 8.7%, with reagents growing 13% driven by volumes and price increases.

In the sole second quarter, overall sales totalled 937 million euros, up 10.1% like for like.

Contributive operating income before non-recurring items (CEBIT) reached 306 million euros for the first half of the year, up 20% like for like. The margin improved by 155 basis points at constant exchange rates.

Net income increased 33% to 215 million euros.

BioMerieux increased its full-year guidance.

It now expects sales to grow organically by 8-10%, compared with a previous estimate of a 6-8% rise, and CEBIT to grow by 12-7% organically, against a prior guidance of an least 10% growth. The full year exchange rates impact is expected to be negative in the range of 70 million euros, up from a previous estimate of 50 million euros.

AAA-Web

(RADIOCOR) 05-09-24 11:52:37 (0265) 5 NNNN